CompanyADMANasdaqRamsey, NJ

Adma Biologics, Inc.

ADMA Biologics manufactures and markets plasma-derived immune globulins for primary immunodeficiency and infectious disease prevention, including FDA-approved ASCENIV, BIVIGAM, and NABI-HB.

Stories only

SEC EDGAR ClinicalTrials.gov ir.admabiologics.com

SCHEDULE 13GAug 7Latest SEC filing

Aug 5Latest story

August 2026

ADMA Biologics reports second quarter 2026 results as ASCENIV revenue climbs 24%

Aug 5Quarterly updateAdma Biologics, Inc.